Substance abuse treatment modalities in the age of HIV spectrum disease.

AMSAODD's Third National Forum on AIDS and Chemical Dependency presented a session about the theory and practicality of combining pharmacologic and nonpharmacologic treatment modalities to maximize the social, psychological, and physical health of patients. Synthesizing methadone maintenance for opioid dependence with abstinence modalities for cocaine dependence and alcoholism was discussed. Chronic adequate methadone treatment allows normalization of neuroendocrine function, is associated with normal natural killer-cell activity, and has proven efficacious in retaining patients in chemical dependence treatment, and thus decreasing the risk for transmission of HIV infection. Individualization of treatment is then exemplified by four clinical vignettes that were discussed by a panel of experts.

[1]  N. Chiorazzi,et al.  Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. , 1989, The Journal of pharmacology and experimental therapeutics.

[2]  Samuel R. Friedman,et al.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. , 1989, JAMA.

[3]  S. Friedman,et al.  Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease. , 1988, Alcoholism, clinical and experimental research.

[4]  M. Kreek,et al.  Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. , 1988, The Journal of infectious diseases.

[5]  S. Batki.  Treatment of intravenous drug users with AIDS: the role of methadone maintenance. , 1988, Journal of psychoactive drugs.

[6]  E. Senay.  Methadone and public policy. , 1988, British journal of addiction.

[7]  M. Kreek.  Opiate-ethanol interactions: implications for the biological basis and treatment of combined addictive diseases. , 1988, NIDA research monograph.

[8]  P. Arns,et al.  Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune status. , 1986, NIDA research monograph.

[9]  M. Kreek,et al.  Acquired immunodeficiency syndrome and infection with hepatitis viruses in individuals abusing drugs by injection. , 1986, Bulletin on narcotics.

[10]  N. Benowitz,et al.  Altered methadone pharmacokinetics in methadone-maintained pregnant women. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  N. Benowitz,et al.  Methadone—Disulfiram Interaction During Methadone Maintenance , 1980, Journal of clinical pharmacology.

[12]  H. Joseph,et al.  LONG‐TERM OUTCOME OF PATIENTS TREATED WITH METHADONE MAINTENANCE * , 1978, Annals of the New York Academy of Sciences.

[13]  M. Kreek,et al.  DRUG INTERACTIONS WITH METHADONE * , 1976, Annals of the New York Academy of Sciences.

[14]  V. Dole,et al.  Methadone maintenance treatment. A ten-year perspective. , 1976, JAMA.

[15]  M. Kreek.  Medical safety and side effects of methadone in tolerant individuals. , 1973, JAMA.